Hyperglycemia News and Research

RSS
Hyperglycemia occurs when you have a higher than usual level of glucose in your blood. This can happen shortly after you have eaten a big meal and is not a problem if your glucose level returns to normal. Cells remove glucose from the blood in response toinsulin. If your pancreas doesn't make enough insulin, glucose can't enter the cells and remains in the blood. Blood glucose levels can also get too high if cells areunable to respond to insulin properly (insulinresistance). Without glucose, your cells are unable to make energy and can't function properly.
Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

Weight loss drug reduces risk of diabetes in patients with pre-diabetes, finds study

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

Study reveals promising new drug candidate to treat acute renal failure

Study reveals promising new drug candidate to treat acute renal failure

Georgia State researcher wins federal grant to study cardiovascular complications in diabetes

Georgia State researcher wins federal grant to study cardiovascular complications in diabetes

Tandem Diabetes Care introduces t:slim X2 Insulin Pump with Basal-IQ Technology in the US

Tandem Diabetes Care introduces t:slim X2 Insulin Pump with Basal-IQ Technology in the US

OHSU professor conducts clinical trial with artificial pancreas using Xeris' liquid glucagon

OHSU professor conducts clinical trial with artificial pancreas using Xeris' liquid glucagon

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Duke Regional Hospital implements Glytec's eGMS to personalize insulin therapy

Duke Regional Hospital implements Glytec's eGMS to personalize insulin therapy

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

FDA expands approval of novel diabetes management device to include younger pediatric patients

FDA expands approval of novel diabetes management device to include younger pediatric patients

FDA approves Eversense CGM system for use in adults with diabetes

FDA approves Eversense CGM system for use in adults with diabetes

Single blood sample can provide adequate confirmation of diabetes

Single blood sample can provide adequate confirmation of diabetes

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

New research reveals links between type 1 diabetes and mental health

New research reveals links between type 1 diabetes and mental health

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

Johns Hopkins' new project helps improve clinician response to deteriorating patient conditions

Johns Hopkins' new project helps improve clinician response to deteriorating patient conditions